EMBC
Embecta Corp.
$3.32
+0.00
(+0.00%)
Mkt Cap
196.97M
Volume
1,725,186
52W Range
2.77-15.55
Sector
Healthcare
Beta
1.05
EPS (TTM)
1.91
P/E Ratio
1.74
Revenue (TTM)
1.04B
Rev Growth (5Y)
-0.1%
EPS Growth (5Y)
-26.2%
Company Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.08B | 1.12B | 1.12B | 1.13B | 1.17B | 1.09B | 1.11B |
| Net Income | 95.40M | 78.30M | 70.40M | 223.60M | 414.80M | 427.60M | 432.00M |
| EPS | 1.64 | 1.36 | 1.23 | 3.92 | 7.31 | 7.50 | 7.58 |
| Free Cash Flow | 182.40M | 19.90M | 41.20M | 388.20M | 417.00M | 456.60M | 436.00M |
| FCF / Share | 3.13 | 0.34 | 0.72 | 6.80 | 7.34 | 8.01 | 7.65 |
| Operating CF | 191.70M | 35.70M | 67.70M | 412.20M | 456.00M | 498.50M | 505.00M |
| Total Assets | 1.09B | 1.29B | 1.21B | 1.09B | 788.00M | 738.00M | 745.00M |
| Total Debt | 1.43B | 1.61B | 1.64B | 1.64B | 0 | 5.00M | 0 |
| Cash & Equiv | 225.50M | 267.50M | 326.30M | 330.90M | 0 | 0 | 0 |
| Book Value | (650.60M) | (738.30M) | (821.70M) | (891.40M) | 594.00M | 572.00M | 577.00M |
| Return on Equity | N/A | N/A | N/A | N/A | 0.70 | 0.75 | 0.75 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 221.80M | 261.20M | 264.00M | 295.50M | 259.00M | 261.90M | 286.10M | 272.50M | 287.20M | 277.30M | 281.90M | 286.10M |
| Net Income | (4.10M) | 44.10M | 26.40M | 45.50M | 23.50M | (700,000) | 14.60M | 14.70M | 28.90M | 20.10M | 6.00M | 15.20M |
| EPS | -0.07 | 0.75 | 0.45 | 0.78 | 0.40 | -0.01 | 0.25 | 0.25 | 0.50 | 0.35 | 0.10 | 0.27 |
| Free Cash Flow | 30.60M | 16.60M | 76.70M | 80.80M | 31.70M | (6.80M) | 26.60M | (11.80M) | 20.90M | (15.80M) | 20.40M | (16.10M) |
| FCF / Share | 0.52 | 0.28 | 1.31 | 1.38 | 0.55 | -0.12 | 0.45 | -0.20 | 0.36 | -0.27 | 0.36 | -0.28 |
| Operating CF | 31.10M | 17.20M | 84.00M | 81.20M | 31.80M | (5.30M) | 26.60M | (2.10M) | 24.30M | (13.10M) | 29.60M | (9.30M) |
| Total Assets | 1.03B | 1.06B | 1.09B | 1.16B | 1.12B | 1.15B | 1.29B | 1.27B | 1.20B | 1.22B | 1.21B | 1.25B |
| Total Debt | 1.36B | 1.42B | 1.43B | 1.50B | 1.55B | 1.58B | 1.61B | 1.65B | 1.66B | 1.64B | 1.64B | 1.64B |
| Cash & Equiv | 184.90M | 204.40M | 225.50M | 230.60M | 209.30M | 210.00M | 267.50M | 275.10M | 299.80M | 298.70M | 326.30M | 317.40M |
| Book Value | (626.10M) | (613.10M) | (650.60M) | (669.60M) | (736.20M) | (768.80M) | (738.30M) | (763.70M) | (769.60M) | (793.50M) | (821.70M) | (809.40M) |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EMBC News
Levi & Korsinsky Investigating Whether Embecta Corp. (EMBC) Misled Investors - Securities Law Violations Possible
EMBC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Embecta Corp. (EMBC) Securities Fraud Investigation - Levi & Korsinsky
Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification
embecta Completes Acquisition of Owen Mumford Holdings Limited
Levi & Korsinsky Announces Investigation of Securities Claims Against Embecta Corp. (EMBC)
Embecta Corp. (EMBC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
EMBC Investor Alert: Levi & Korsinsky Investigates Embecta Corp. (EMBC) for Potential Securities Fraud
embecta to Participate at the 2026 BofA Securities Global Health Care Conference
EMBC ACTIVE INVESTIGATION: Lost Money on Embecta Corp.? Contact Levi & Korsinsky Now